Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
United European Gastroenterol J. 2023 Jul 25. doi: 10.1002/ueg2.12443. Online ahead of print.
ABSTRACT
Lifestyle modification comprising calorie restriction (CR) and increased physical activity enabling weight loss is the first-line of treatment for non-alcoholic fatty liver disease (NAFLD). However, CR alone is not optimal and evidence suggests that dietary pattern and composition are also critical in NAFLD management. Accordingly, high consumption of red and processed meat, saturated fat, added sugar, and sweetened beverages are associated with an increased risk of developing NAFLD and hepatocellular carcinoma, while other foods and compounds such as fish, olive oil, and polyphenols are, in contrast, beneficial for metabolic disorders. Therefore, several dietary interventions have been studied in order to determine which strategy would be the most beneficial for NAFLD. The evidence regarding the effectiveness of different dietary interventions such as low carbohydrate/low-fat diet, time-restricted eating diet, CR, and the well-studied Mediterranean diet is summarized.
PMID:37491835 | DOI:10.1002/ueg2.12443
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Management of Cardiovascular Risk in the Non-alcoholic Fatty Liver Disease Setting Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice Comparative effects of viable Lactobacillus rhamnosus GG and its heat-inactivated paraprobiotic in the prevention of high-fat high-fructose diet-induced non-alcoholic fatty liver disease in rats Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison Thermoneutrality Inhibits Thermogenic Markers and Exacerbates Nonalcoholic Fatty Liver Disease in Mice Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication The association between endocrine disrupting chemicals and nonalcoholic fatty liver disease: A systematic review and meta-analysis Increase in bile acids after sleeve gastrectomy improves metabolism by activating GPBAR1 to increase cAMP in mice with nonalcoholic fatty liver disease Strong association between sarcopenic obesity and non-alcoholic fatty liver disease: Anobservational study with ISarcoPRMalgorithm Mediating effect of diabetes on the relationship between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease: a prospective cohort study Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice Are dietary factors associated with cardiometabolic risk factors in patients with non-alcoholic fatty liver disease? Association between nonalcoholic steatohepatitis and high serum ferritin levels in type 2 diabetes mellitus Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD Association between nonalcoholic fatty liver disease scores and chronic periodontitis: A retrospective cohort study Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARalpha Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARalpha Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease Effective roles of exercise and diet adherence in non-alcoholic fatty liver disease Liver Fatty Acid-binding Protein Is a More Reliable Biomarker for Liver Injury in Nonalcoholic Steatohepatitis than Other Etiologies of Hepatitis Interaction of periodontal clinical indicators in metabolic syndrome and nonalcoholic fatty liver disease: Implications for preventive interventions EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Dietary inflammatory index and the risks of non-alcoholic fatty liver disease: a systematic review and meta-analysis An novel effective and safe model for the diagnosis of nonalcoholic fatty liver disease in China: gene excavations, clinical validations, and mechanism elucidation Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia Prevalence and Association of Risk Factors According to Liver Steatosis and Fibrosis Stages among Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus in India: A Cross-sectional Study A novel bellidifolin intervention mitigates nonalcoholic fatty liver disease-like changes induced by bisphenol F The role and mechanism of SUMO modification in liver disease Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway Triglyceride-glucose-alanine aminotransferase index: A noninvasive serum predictor for identifying the severity of pediatric nonalcoholic fatty liver disease Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation The rs1862513 promoter variant of resistin gene influences susceptibility to nonalcoholic fatty liver disease Association between non-alcoholic fatty liver disease and metabolic abnormalities in children with different weight statuses Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease Soluble dietary fiber from Dendrocalamus brandisii (Munro) Kurz shoot improves liver injury by regulating gut microbial disorder in mice Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study Dietary and genetic determinants of non-alcoholic fatty liver disease in coronary heart disease patients Dietary and genetic determinants of non-alcoholic fatty liver disease in coronary heart disease patients NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers Effectiveness of Mobile Health Intervention for Non Alcoholic Fatty Liver Disease- A Meta Analysis of Randomized Controlled Trials RNA modifications in the progression of liver diseases: from fatty liver to cancer RNA modifications in the progression of liver diseases: from fatty liver to cancer Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact Effect of statin use on liver enzymes and lipid profile in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Effect of statin use on liver enzymes and lipid profile in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Evidence Blueprint
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Association of fish and meat consumption with non-alcoholic fatty liver disease: Guangzhou Biobank Cohort Study Association between processed and unprocessed red meat consumption and risk of nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease Management of Cardiovascular Risk in the Non-alcoholic Fatty Liver Disease Setting Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: a prospective cohort study Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials Bidirectional association between non-alcoholic fatty liver disease and fatty pancreas: a systematic review and meta-analysis Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action Analysis of the association between dietary patterns and nonalcoholic fatty liver disease in a county in Guangxi The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review Therapeutic management of metabolic dysfunction associated steatotic liver disease Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity Correlation of Nonalcoholic Fatty Liver Disease with Dietary Folate and Serum Folate in U.S. Adults: Cross-Sectional Analyses from National Health and Nutrition Examination Survey 2009-2018 The Role of PNPLA3_rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice Food co-consumption network as a new approach to dietary pattern in non-alcoholic fatty liver disease Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications Comparative effects of viable Lactobacillus rhamnosus GG and its heat-inactivated paraprobiotic in the prevention of high-fat high-fructose diet-induced non-alcoholic fatty liver disease in rats Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver? What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver? Dietary pattern in women with polycystic ovary syndrome with and without associated non-alcoholic fatty liver disease: A cross-sectional study Intake of the different types of dairy products, genetic predisposition, and the risks of nonalcoholic fatty liver disease and cirrhosis: a prospective cohort study Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study Liver integrity and the risk of Alzheimer's disease and related dementias Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review Anthocyanin: A Potential Phytochemical Candidate for the Amelioration of Non-Alcoholic Fatty Liver Disease Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non-alcoholic fatty liver disease: Focus on oxidative stress and inflammation Dietary Nε-(carboxymethyl)lysine is a trigger of non-alcoholic fatty liver disease under high-fat consumption Natural compounds proposed for the management of non-alcoholic fatty liver disease A systematic review on factors associated with non-alcoholic fatty liver disease (NAFLD) among adolescents Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD) The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step? Thermoneutrality Inhibits Thermogenic Markers and Exacerbates Nonalcoholic Fatty Liver Disease in Mice Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity The impacts of Ramadan fasting for patients with non-alcoholic fatty liver disease (NAFLD): a systematic review The effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance, and anthropometric measurements in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial